[
  {
    "ts": null,
    "headline": "Viatris (VTRS) Announces Positive Top-line Results from VEGA-3",
    "summary": "Viatris Inc. (NASDAQ:VTRS) is one of the Most Undervalued Stocks Under $10 to Buy Now. The company announced positive top-line results from VEGA-3, which is the second pivotal Phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) in treating presbyopia. To give a brief overview, presbyopia happens to be a progressive loss of the ability to […]",
    "url": "https://finnhub.io/api/news?id=ed56c23a2fc8447d43a0d7216da1c2581305c251f3a225e426704b3852656117",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752734780,
      "headline": "Viatris (VTRS) Announces Positive Top-line Results from VEGA-3",
      "id": 135994792,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris Inc. (NASDAQ:VTRS) is one of the Most Undervalued Stocks Under $10 to Buy Now. The company announced positive top-line results from VEGA-3, which is the second pivotal Phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) in treating presbyopia. To give a brief overview, presbyopia happens to be a progressive loss of the ability to […]",
      "url": "https://finnhub.io/api/news?id=ed56c23a2fc8447d43a0d7216da1c2581305c251f3a225e426704b3852656117"
    }
  },
  {
    "ts": null,
    "headline": "Q1 Earnings Highs And Lows: Viatris (NASDAQ:VTRS) Vs The Rest Of The Generic Pharmaceuticals Stocks",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how generic pharmaceuticals stocks fared in Q1, starting with Viatris (NASDAQ:VTRS).",
    "url": "https://finnhub.io/api/news?id=30b58000ba5333f393ce48285e041d35f2638e5262db6ffcdbe725b152d2faba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752723330,
      "headline": "Q1 Earnings Highs And Lows: Viatris (NASDAQ:VTRS) Vs The Rest Of The Generic Pharmaceuticals Stocks",
      "id": 135997080,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how generic pharmaceuticals stocks fared in Q1, starting with Viatris (NASDAQ:VTRS).",
      "url": "https://finnhub.io/api/news?id=30b58000ba5333f393ce48285e041d35f2638e5262db6ffcdbe725b152d2faba"
    }
  }
]